Condition: Alzheimer Type Dementia · Sponsor: Bigespas LTD
The goal of this clinical study is to learn if the study drug DMB-I (INN: Latrepirdine) works to treat Alzheimer type dementia in adults. It will also learn about the safety of DMB-I (INN: Latrepirdine). The main questions it aims to answer are: * Does DMB-I improve cognitive functions in patients with dementia associated with Alzheimer's disease, and how sigificant the improvement is? * What medical problems do participants have when taking DMB-I? Researchers will compare DMB-I to a placebo (a look-alike substance that contains no drug) to see if the study drug works to treat Alzheimer type dementia. * Is DMB-I effective and safe when taken long-term? Participants will: Take the study drug or a placebo (with or without Akatinol Memantine®) every day for 26 weeks at Stage 1 of the study, and take the study drug (with or without Akatinol Memantine®) every day for 26 weeks at Stage 2 of the study. Visit the clinic 13 times for checkups and tests Keep a diary of their symptoms
This description comes directly from the study's public registry record.
Anna Rashina · +74952761143 · aar@ipharma.ru
Always discuss trial participation with your own doctor first.
| State autonomous healthcare institution "Transregional Clinical Diagnostic Center" | Kazan', Russia | Recruiting |
| Moscow State budgetary healthcare institution "City Clinical Hospital named after V.M. Buyanov of the Moscow Healthcare Department" | Moscow, Russia | Recruiting |
| Federal State Budgetary Institution "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency | Moscow, Russia | Recruiting |
| Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) | Moscow, Russia | Recruiting |
| Nizhny Novgorod region State budgetary healthcare institution " Nizhny Novgorod Clinical Psychiatric Hospital No. 1" | Nizhny Novgorod, Russia | Recruiting |
| State budgetary healthcare institution "Leningrad Regional Mental Health Center" | Roshchino, Russia | Recruiting |
| "Medical Center Nova Vita" LLC | Rostov-on-Don, Russia | Recruiting |
| Saint Petersburg State budgetary healthcare institution "Psychiatric Hospital No. 1 named after P.P. Kashchenko" | Saint Petersburg, Russia | Recruiting |
| "Medical services" LLC | Saint Petersburg, Russia | Recruiting |
| Saint Petersburg State budgetary healthcare institution "Psychoneurologic dispensary № 5" | Saint Petersburg, Russia | Recruiting |
| "Sphera Med" LLC | Saint Petersburg, Russia | Recruiting |
| Saint Petersburg State budgetary healthcare institution "City Hospital No. 40 of Kurortniy district" | Saint Petersburg, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07251023